Vaxart hosted a Stockholder Fireside Chat to discuss the upcoming special meeting and the proposed reverse stock split.
Management highlighted the company's commitment to developing oral pill vaccine candidates and clarifying misconceptions about the business.
The discussion emphasized the alignment of Vaxart's interests with its stockholders' investment goals.
Rationale for Reverse Stock Split
The purpose of the proposed reverse stock split was explained, focusing on providing clarity and addressing questions from stockholders.
Commitment to Science and Product Development
Vaxart's dedication to proving the effectiveness of its unique oral pill vaccines and maximizing investor value through commercial product launches or partnerships.
Benefits of NASDAQ Listing
The advantages of listing on NASDAQ were highlighted, including access to institutional investors, partnership opportunities, and enhanced oversight for shareholder protection.
- Vaxart aims to transform vaccine delivery with oral options that offer benefits over traditional needle vaccines.
- Listing on NASDAQ is crucial for advancing scientific programs and securing support for the company's long-term drug development efforts.
Vaxart's Stockholder Fireside Chat emphasized the company's dedication to innovation in vaccine development and the importance of stockholder support for future growth and success.